DUBLIN, Apr. 13, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Hospital Infection Prevention And Control Market, 2013 to 2024" report to their offering.
The global hospital infection prevention and control market was valued at US$ 142.6 Mn in 2015, and is expected to reach US$ 245.6 Mn by 2024, expanding at a CAGR of 6.3% from 2016 to 2024.
The market experts suggest that healthcare associated infections are a costly issue faced by many hospitals across the globe. Hospital acquired infections are type of infections that are observed in patients during the course of receiving treatment for unrelated conditions. According to the World Health Organization (WHO), infectious waste contributes in this way to the risk of nosocomial infections, putting the health of hospital personnel, and patients, at risk. The Centers for Disease Control and Prevention (CDC) statistically suggested that, with approximately 300,000 occurrences each year, surgical site infections (SSIs) are the second most prevalent HAI in the United States, preceded only by urinary tract infections. At a cost of approximately US$ 10 Bn annually, this high incidence of SSIs significantly impacts the U.S. healthcare system, as well as the bottom line of individual hospitals.
The occurrence of nosocomial infections has been observed worldwide in both developed and resource-poor countries. Key factors assisting the growth of hospital infections prevention and control market are rising prevalence of infections, implementation of stringent guidelines associated with hospital infection prevention and control, developing healthcare infrastructure in emerging countries, and rising number of hospitals across the world.
- 3M Company
- Ansell Ltd.
- Becton, Dickinson and Company
- Belimed AG
- Bemis Company, Inc.
- B. Braun Melsungen AG
- Cantel Medical Corp.
Key Topics Covered:
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Global Hospital Infection Prevention and Control Market Overview
Chapter 4 Global Hospital Infection Prevention and Control Market, by Infection Type
Chapter 5 Global Hospital Infection Prevention & Control Analysis, by Product
Chapter 6 Global Hospital Infection Prevention and Control Market, By Geography
Chapter 7 Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/9rdt92/global_hospital
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/research-and-markets---global-hospital-infection-prevention-and-control-market-report-2017-key-players-are-3m-company-ansell-belimed-ag-bemis-company-braun--cantel-medical-300439426.html
SOURCE Research and Markets